GET DAILY SIGNALSGevo (GEVO): Evaluating the +250% Path to the $5.20 Analyst Target
Key Takeaways
- The central $5.20 target is the arithmetic mean of four verified analyst price targets, which range from $1.50 to $14.00.
- At a recent price near $1.47, reaching $5.20 would require a gain of roughly 250% — a very large move.
- The range is unusually wide because H.C. Wainwright's $14.00 target is a significant outlier relative to the other three targets of $1.50, $2.25, and $3.00.
- Supporting factors include a U.S. Department of Energy (DOE) loan commitment for the Net-Zero 1 SAF project and rapid top-line growth, while risks include ongoing net losses, financing needs, and policy dependence.
- For more context on Gevo's Major News, Today's Price Move, Forecast, and Earnings, explore these dedicated pages.
- Explore Trending AI Robots to see how AI-driven tools are being applied to stock and ETF analysis.
Understanding the Analyst Price Targets
The $5.20 figure represents the arithmetic mean of four recent analyst targets rather than an official consensus. These include H.C. Wainwright at $14.00 (Buy), Northland Securities' Jeff Grampp at $3.00 (Buy/Outperform), UBS at $2.25 (Neutral), and Jefferies at $1.50 (Hold). Averaging those values produces roughly $5.19, which rounds to the $5.20 level I am focusing on here.
The spread from $1.50 to $14.00 highlights real differences in how analysts view execution risk and valuation at GEVO. H.C. Wainwright's high target assumes successful scaling of the Net-Zero 1 project, while the lower targets from Jefferies and UBS reflect caution around financing and commercialization timelines. Northland's $3.00 target, reiterated in December 2025, sits in the middle. UBS raised its target to $2.25 from $1.15 in September 2025 but kept a Neutral rating due to questions about the DOE loan.
Current Market Position and Required Move
GEVO shares closed near $1.47 in early November 2026, within a 52-week range of $1.09 to $2.97. The company is a micro-cap with a market capitalization of roughly $350 million. Reaching $5.20 from current levels would require an increase of about 250%, a substantial move by any standard.
Revenue has grown quickly, with trailing twelve-month sales near $177.5 million, up more than 120% year over year. However, the company continues to post large net losses exceeding $200 million and negative EPS. Progress toward the target therefore depends more on financing and building out SAF capacity than on near-term earnings.
Factors That Could Support Higher Prices
The DOE loan commitment for the Net-Zero 1 facility stands out as a key de-risking step for the project. Structural demand for sustainable aviation fuel, backed by airline goals and incentives such as the 45Z production credit, provides additional tailwinds. Existing ethanol, renewable natural gas, and carbon sequestration operations supply near-term revenue that can support further development.
Additional offtake agreements and continued revenue growth could prompt analysts to raise targets over time. I also checked this using Tickeron’s AI Daily Buy/Sell Signals to see how recent price action compares with historical patterns.
Risks That Could Limit Upside
Execution and funding remain the main hurdles. GEVO is still in an early build-out phase, and its valuation assumes significant future growth. Delays, cost overruns, or weaker offtake could pressure multiples. Dependence on policy support, including DOE financing and clean fuel credits, adds another layer of uncertainty.
Ongoing losses may require further capital raises, potentially diluting shareholders. The wide analyst range and some negative insider sentiment suggest that many on the Street view the higher targets as speculative.
Technical Levels to Watch
The stock gained more than 20% in a week after touching a 52-week low near $1.09 in late October 2026. Near-term support lies in the $1.20-to-$1.30 area, with $1.09 as a stronger floor. Resistance appears around $1.50-to-$1.60, then $2.00, and the 52-week high near $2.97. A sustained move to $5.20 would require clearing all of these levels and maintaining an uptrend over multiple quarters.
Key Items for Investors to Monitor
Analyst targets generally look out about 12 months. Investors should track third-quarter earnings, updates on financing and project timelines, any shifts in the DOE loan commitment, analyst revisions, and policy changes around the 45Z credit. Quarterly details on construction progress, offtake agreements, and cash burn will be especially useful in assessing whether the higher targets remain realistic.
Incorporating AI Tools in My Research
When reviewing stocks like GEVO, I often cross-check my fundamental views with Tickeron's AI Daily Buy/Sell Signals. This tool applies artificial intelligence to scan thousands of stocks and ETFs, producing Buy, Sell, or Hold signals based on technical behavior and market conditions. It helps me spot shifts more efficiently and adds a quantitative perspective that complements traditional analysis. I find it particularly useful for monitoring momentum around key project milestones.
Final Assessment
The $5.20 target is simply the average of four analyst estimates that stretch from $1.50 to $14.00, a spread wide enough that the headline number is heavily influenced by the H.C. Wainwright outlier. Achieving that level from recent prices near $1.47 would require a roughly 250% gain, a challenging outcome for a micro-cap still posting substantial losses. The bullish case rests on successful execution of Net-Zero 1 and steady policy support, while the bearish view centers on financing risk and commercialization uncertainty. The split between Buy and Neutral ratings reflects honest disagreement rather than broad conviction. Focus on financing progress, project updates, and cash-flow trends instead of relying on any single target.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
GEVO in +20.49% Uptrend, rising for three consecutive days on November 09, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where GEVO advanced for three days, in 187 of 223 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 28, 2026. You may want to consider a long position or call options on GEVO as a result. In 72 of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 77%.
The Moving Average Convergence Divergence (MACD) for GEVO just turned positive on October 27, 2026. Looking at past instances where GEVO's MACD turned positive, the stock continued to rise in 38 of 47 cases over the following month. The odds of a continued upward trend are 81%.
GEVO moved above its 50-day moving average on November 06, 2026 date and that indicates a change from a downward trend to an upward trend.
Bearish Trend Analysis
The 10-day RSI Indicator for GEVO moved out of overbought territory on November 10, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In 27 of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GEVO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
GEVO broke above its upper Bollinger Band on November 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for GEVO entered a downward trend on November 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 22 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 38 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.258) is normal, around the industry mean (2.284). P/E Ratio (-1.544) is within average values for comparable stocks, (-17.137). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.548). Dividend Yield (0.000) settles around the average of (0.039) among similar stocks. P/S Ratio (2.012) is also within normal values, averaging (48.960).
The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating fairly steady price growth. GEVO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GEVO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a company which engages in the development and commercialization of alternatives to petroleum-based products
Industry ChemicalsSpecialty
Advertisement